Ginkgo Bioworks

company

About

Ginkgo Bioworks is a developer of biological engineering products and custom microbes across multiple markets.

  • 501 - 1000

Details

Last Funding Type
Grant
Last Funding Money Raised
$180K
Industries
Biopharma,Biotechnology,Chemical
Founded date
Jan 1, 2008
Number Of Employee
501 - 1000
Operating Status
Active

Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria to protect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$101.67M
Ginkgo Bioworks has raised a total of $101.67M in funding over 2 rounds. Their latest funding was raised on Jun 8, 2016 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 8, 2016 Series C $100M 1 Detail
Dec 2, 2014 Grant $179.99K 1 National Science Foundation Detail
Apr 9, 2013 Grant $1.31M 1 National Science Foundation Detail
Dec 10, 2012 Grant $180K 1 National Science Foundation Detail

Investments

Number of Investments
Number of Lead Investments
1
1
Ginkgo Bioworks has made 1 investments. Their most recent investment was on Jun 12, 2019, when Synlogic raised $80M.
Date Company Name
Round Money Raised Industry Lead Investor
Jun 12, 2019 Synlogic
Post-IPO Equity $80M Biotechnology Yes

Investors

Number of Lead Investors
Number of Investors
3
2
Ginkgo Bioworks is funded by 2 investors. National Science Foundation and Allen & Company are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Allen & Company Series C